Anping Cai

TL;DR: The present review focuses on the current understanding of OSA-associated hypertension, the potential approaches for treatment of OSO and the effect of Osa treatment on hypertension management, and it is hoped the present review will shed light for future studies that investigate effective therapeutic strategies to simultaneously improve the management of O SA and hypertension.

TL;DR: 3‐Hydroxy‐methylglutaryl‐coenzyme A (HMG‐CoA) reductase inhibitors or statins are a class of medications with potent effects on reducing serum cholesterol level, and currently have been widely used in the primary and secondary prevention of atherosclerotic cardiovascular diseases (ASCVD).

TL;DR: The present review is going to summarize the relevant data about the bio-chemical characteristics of Lp-PLA2, the actions of LP- PLA2 on atherosclerosis and the results of L p-PLA1 in scientific research and clinical studies.

TL;DR: IGF-1 dose-dependently stimulated the proliferation of MSCs, upregulated the expression of CXCR4, and accelerated migration, all in a dose-dependent manner, while the optimal concentration of IGF-1 on proliferation and migration was different.

TL;DR: Significant evidence is presented that circulating miR-92a represents a potential noninvasive atherosclerosis marker in essential hypertensive patients and a significant positive correlation with 24-h mean systolic BP levels.